SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
53 hedge funds and large institutions have $33.5M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 10 closing their positions.
Holders
53
Holders Change
-6
Holders Change %
-10.17%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
12
Reduced
7
Closed
10
Calls
$828K
Puts
$1K
Net Calls
+$827K
Net Calls Change
+$128K
Top Buyers
1 |
APM
1
Avidity Partners Management
Dallas,
Texas
|
$4.61M |
2 |
DMKJ
2
David M. Knott Jr
|
$303K |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$409K |
4 |
4
BlackRock
New York
|
$665K |
5 |
SC
5
Shay Capital
New York
|
$83.2K |